FREDERICK, Md., March 11, 2014 /PRNewswire/
-- BioElectronics Corporation (OTC Pink: BIEL), the maker of
advanced consumer medical devices has appointed Dr. Deepak Kotak MA (Oxford), MBBS, FRCA, MRCP, LLDip, LLM as
Executive Vice President.
"Dr. Kotak brings a wealth of knowledge and experience that will
help lead BioElectronics to the next level of development," said
Andrew J. Whelan, BioElectronics
President. "Dr Kotak has a rare and valuable combination of
credentials: medical, legal, pharmaceutical and
entrepreneurial."
With the appointment of Dr. Kotak who lives in London, BioElectronics will have a greater
presence in Europe to further
promote the ActiPatch Therapy product line that is available OTC in
Boots. Dr. Kotak will provide leadership and management for the
RecoveryRx product line as well as undertaking medical affairs,
clinical research and new product development activities. He joins
BioElectronics at an exciting time as international sales begin to
gain greater traction and after the very recent recommendation by
the FDA to reclassify Shortwave Medical Devices to Class II.
Prior to his appointment, Dr. Kotak has been Chief Medical
Officer of TraumaTec, a Houston
medical device company as well as a consultant to the Boss Group
and Blackstone Valley Group, two private equity firms.
Dr. Kotak brings a broad medical background and perspective
having practiced as a specialist in intensive care medicine,
anesthesia and trauma in a London
teaching hospital. Dr. Kotak has also practiced for four years as a
civil lawyer. Dr. Kotak graduated in medicine with degrees from
Oxford University and the University of
London.
About BioElectronics Corporation
BioElectronics
Corporation is a leader in biophysics and the maker of an industry
leading family of disposable, drug-free, pain therapy devices:
ActiPatch® Therapy, over-the-counter treatment for back
pain and other musculoskeletal complaints; RecoveryRx®
Devices for chronic and post-operative wound care;
Allay® Menstrual Pain Therapy; and HealFast®
Therapy for dogs, cats and horses. For more information,
please visit www.bielcorp.com.
BioElectronics Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com
SOURCE BioElectronics Corporation